LISATA THERAPEUTICS, INC. — Director's Dealing 2013

Jan 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2013-01-04

Reporting Person: MYERS STEVEN S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-04	Common stock, par value $0.001 per share	A	170000	—	Acquired	1244606	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.001 per share	195313	Indirect

Footnotes

F1: On January 4, 2013 (the "Grant Date"), the Reporting Person was granted an award of 170,000 shares of the Issuer's common stock, subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan and pursuant to the Issuer's Director Compensation Plan. The award was fully vested on the Grant Date.